Selective activation of Galphao by D2L dopamine receptors in NS20Y neuroblastoma cells - PubMed (original) (raw)
Selective activation of Galphao by D2L dopamine receptors in NS20Y neuroblastoma cells
V J Watts et al. J Neurosci. 1998.
Abstract
D2L dopamine receptor activation results in rapid inhibition and delayed heterologous sensitization of adenylate cyclase in several host cell types. The D2L dopamine receptor was stably transfected into NS20Y neuroblastoma cells to examine inhibition and sensitization in a neuronal cell environment and to identify the particular G-proteins involved. Acute activation of D2L receptors with the selective D2 agonist quinpirole inhibited forskolin-stimulated cAMP accumulation, whereas prolonged incubation (2 hr) with quinpirole resulted in heterologous sensitization (more than twofold) of forskolin-stimulated cAMP accumulation in NS20Y-D2L cells. To unambiguously identify the pertussis toxin (PTX)-sensitive G-proteins responsible for inhibition and sensitization, we used viral-mediated gene delivery to assess the ability of genetically engineered PTX-resistant G-proteins (Galphai1*, Galphai2*, Galphai3*, and Galphao*) to rescue both responses after PTX treatment. The expression and function of individual recombinant G-proteins was confirmed with Western blotting and inhibition of GTPgammaS-stimulated adenylate cyclase, respectively. To assess the specificity of D2L-Galpha coupling, cells were infected with herpes simplex virus (HSV) recombinants expressing individual PTX-resistant G-protein alpha subunits and treated with PTX, and quinpirole-induced responses were measured. Infection of NS20Y-D2L cells with HSV-Galphao* rescued both inhibition and sensitization in PTX-treated cells, whereas infection with HSV-Galphai1*, HSV-Galphai2*, or HSV-Galphai3* failed to rescue either response. In summary, the current study provides strong evidence that the D2L dopamine receptor couples to Galphao in neuronal cells, and that this coupling is responsible for both the acute and subacute effects of D2 receptor activation on adenylate cyclase activity.
Figures
Fig. 1.
Specificity of D2L receptor-mediated inhibition of cAMP accumulation. cAMP accumulation was stimulated by forskolin (10 μ
m
) in NS20Y-D2L cells in the absence or presence of quinpirole (1 μ
m
) or dopamine (1 μ
m
) for 15 min. As indicated in the figure, some experiments were performed in the presence of 1 μ
m
spiperone (+ Spip) or 1 μ
m
SCH23390 (+ SCH). Data shown are the mean ± SE of three to four independent experiments, each assayed in duplicate. *p < 0.01 compared with vehicle-treated cells (Dunnett’s post-repeated measures ANOVA).
Fig. 2.
Potency of quinpirole for inhibition and sensitization of forskolin-stimulated cAMP accumulation. Each point is the average of duplicate determinations, expressed as a percentage of forskolin-stimulated activity in the absence of quinpirole (•,Inhibition) or after 2 hr pretreatment with 10 μ
m
quinpirole (○, Sensitization). Dose–response curves for quinpirole inhibition of cAMP accumulation were determined in NS20Y-D2L cells stimulated with 10 μ
m
forskolin and increasing concentrations of quinpirole for 15 min. For sensitization, NS20Y-D2L cells were treated with increasing concentrations of quinpirole for 2 hr and washed, and cAMP accumulation was stimulated with 10 μ
m
forskolin. The experiments shown are representative of three independent experiments. In the inhibition curve shown, the maximal inhibition was 88% and the IC50 value was 3.3 n
m
. Forskolin stimulation in the absence of quinpirole was 135 pmol/well. The EC50 value for sensitization was 18 n
m
; forskolin-stimulated cAMP accumulation was 130 pmol/well in vehicle-treated cells and 320 pmol/well in cells treated with 10 μ
m
quinpirole.
Fig. 3.
D2 agonist-induced heterologous sensitization. NS20Y-D2L cells were treated with vehicle, quinpirole (1 μ
m
), or dopamine (1 μ
m
) for 2 hr at 37°C. Where indicated, some agonist treatments were completed in the presence of 1 μ
m
spiperone (+ Spip) or after overnight treatment with 50 ng/ml pertussis toxin (+ PTX). Cells were extensively washed, and cAMP accumulation was stimulated with forskolin (10 μ
m
) for 15 min. Data shown are the mean ± SE of four to six independent experiments, each assayed in duplicate. *p < 0.01 compared with vehicle-treated cells (Dunnett’s post-repeated measures ANOVA).
Fig. 4.
Expression of HSV-Gαi1*, -Gαi2*, -Gαi3*, and -Gαo* in NS20Y-D2L cell membranes. Lane 1 of each gel was loaded with 50 μg of control NS20Y-D2L cell membranes from an enriched membrane preparation (EP) as described in Materials and Methods. Lanes 2 and _3_were loaded with 10 μg of cell membranes from a standard membrane preparation (StdP) of control and HSV-Gαi1*, -Gαi2*-, -Gαi3*-, or -Gαo*-infected cells (18 hr), and Western analysis was completed using corresponding α subunit specific antibodies. The data shown are from a single experiment representative of three independent experiments.
Fig. 5.
Gα subunit specificity for inhibition of cAMP accumulation in NS20Y-D2L cells. Quinpirole-induced inhibition of forskolin-stimulated cAMP accumulation was examined in cells infected with PTX-resistant HSV-Gα subunits. NS20Y-D2L cells were untreated (Control), infected with HSV-LacZ, or infected with individual PTX-resistant Gα subunits for 18 hr. cAMP accumulation was stimulated with forskolin (10 μ
m
) in the presence or absence of quinpirole (10 μ
m
) for 15 min. Where indicated, cAMP accumulation was assessed after 6 hr treatment with 100 ng/ml pertussis toxin (PTX). Data shown are the mean ± SE of four or more independent experiments, assayed in duplicate. **p < 0.01, *p < 0.05 compared with forskolin alone (Student’s t test).
Fig. 6.
Gα subunit specificity for heterologous sensitization in NS20Y-D2L cells. Quinpirole-induced sensitization of forskolin-stimulated cAMP accumulation was examined in cells infected with PTX-resistant HSV-Gα subunits. NS20Y-D2L cells were untreated (Control), infected with HSV-LacZ, or infected with individual PTX-resistant Gα subunits for 18 hr. NS20Y-D2L cells were incubated in the presence or absence of quinpirole (10 μ
m
) for 2 hr and extensively washed, and cAMP accumulation was stimulated with forskolin (10 μ
m
) for 15 min. Some experiments were completed after pertussis toxin (PTX) treatment. Cells were initially treated with PTX (500 ng/ml) for 2 hr, followed by a 2 hr incubation with quinpirole in the presence of PTX (250 ng/ml). Data shown are the mean ± SE of five to seven independent experiments, assayed in duplicate. **p < 0.01 compared with matched vehicle-treated cells (Student’s t test).
Similar articles
- Adrenergic agonists induce heterologous sensitization of adenylate cyclase in NS20Y-D(2L) cells.
Johnston CA, Cumbay MG, Vortherms TA, Watts VJ. Johnston CA, et al. FEBS Lett. 2001 May 25;497(2-3):85-9. doi: 10.1016/s0014-5793(01)02442-5. FEBS Lett. 2001. PMID: 11377418 - Distinct roles for Galphai2, Galphai3, and Gbeta gamma in modulation offorskolin- or Gs-mediated cAMP accumulation and calcium mobilization by dopamine D2S receptors.
Ghahremani MH, Cheng P, Lembo PM, Albert PR. Ghahremani MH, et al. J Biol Chem. 1999 Apr 2;274(14):9238-45. doi: 10.1074/jbc.274.14.9238. J Biol Chem. 1999. PMID: 10092597 - Adenylyl cyclase interaction with the D2 dopamine receptor family; differential coupling to Gi, Gz, and Gs.
Obadiah J, Avidor-Reiss T, Fishburn CS, Carmon S, Bayewitch M, Vogel Z, Fuchs S, Levavi-Sivan B. Obadiah J, et al. Cell Mol Neurobiol. 1999 Oct;19(5):653-64. doi: 10.1023/a:1006988603199. Cell Mol Neurobiol. 1999. PMID: 10384262 - Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors.
Watts VJ, Neve KA. Watts VJ, et al. Mol Pharmacol. 1996 Oct;50(4):966-76. Mol Pharmacol. 1996. PMID: 8863843 - Dopamine D2 receptors in signal transduction and behavior.
Picetti R, Saiardi A, Abdel Samad T, Bozzi Y, Baik JH, Borrelli E. Picetti R, et al. Crit Rev Neurobiol. 1997;11(2-3):121-42. doi: 10.1615/critrevneurobiol.v11.i2-3.20. Crit Rev Neurobiol. 1997. PMID: 9209827 Review.
Cited by
- Activation of Trace Amine-Associated Receptor 1 Stimulates an Antiapoptotic Signal Cascade via Extracellular Signal-Regulated Kinase 1/2.
Shi X, Swanson TL, Miner NB, Eshleman AJ, Janowsky A. Shi X, et al. Mol Pharmacol. 2019 Oct;96(4):493-504. doi: 10.1124/mol.119.116798. Epub 2019 Aug 13. Mol Pharmacol. 2019. PMID: 31409621 Free PMC article. - Activation of B-Raf and regulation of the mitogen-activated protein kinase pathway by the G(o) alpha chain.
Antonelli V, Bernasconi F, Wong YH, Vallar L. Antonelli V, et al. Mol Biol Cell. 2000 Apr;11(4):1129-42. doi: 10.1091/mbc.11.4.1129. Mol Biol Cell. 2000. PMID: 10749919 Free PMC article. - Most central nervous system D2 dopamine receptors are coupled to their effectors by Go.
Jiang M, Spicher K, Boulay G, Wang Y, Birnbaumer L. Jiang M, et al. Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3577-82. doi: 10.1073/pnas.051632598. Epub 2001 Mar 6. Proc Natl Acad Sci U S A. 2001. PMID: 11248120 Free PMC article. - Genetic Polymorphisms Affect Mouse and Human Trace Amine-Associated Receptor 1 Function.
Shi X, Walter NA, Harkness JH, Neve KA, Williams RW, Lu L, Belknap JK, Eshleman AJ, Phillips TJ, Janowsky A. Shi X, et al. PLoS One. 2016 Mar 31;11(3):e0152581. doi: 10.1371/journal.pone.0152581. eCollection 2016. PLoS One. 2016. PMID: 27031617 Free PMC article. - G-protein alpha subunit isoforms couple differentially to receptors that mediate presynaptic inhibition at rat hippocampal synapses.
Straiker AJ, Borden CR, Sullivan JM. Straiker AJ, et al. J Neurosci. 2002 Apr 1;22(7):2460-8. doi: 10.1523/JNEUROSCI.22-07-02460.2002. J Neurosci. 2002. PMID: 11923410 Free PMC article.
References
- Ammer H, Schulz R. Morphine dependence in human neuroblastoma SH-SY5Y cells is associated with adaptive changes in both the quantity and functional interaction of PGE1 receptors and stimulatory G proteins. Brain Res. 1996;707:235–244. - PubMed
- Ammer H, Schulz R. Enhanced stimulatory adenylyl cyclase signaling during opioid dependence is associated with a reduction in palmitoylated Gsα. Mol Pharmacol. 1997;52:993–999. - PubMed
- Avidor-Reiss T, Nevo I, Levy R, Pfeuffer T, Vogel Z. Chronic opioid treatment induces adenylyl cyclase V superactivation: involvement of Gβγ. J Biol Chem. 1996;271:21309–21315. - PubMed
- Bates MD, Senogles SE, Bunzow JR, Liggett SB, Civelli O, Caron MG. Regulation of responsiveness at D2 dopamine receptors by receptor desensitization and adenylyl cyclase sensitization. Mol Pharmacol. 1991;39:55–63. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources